Biotech startups that raised Series A in Germany
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Cellbox Solutions | Cologne | Series A | $1.7M | 2026-10-20 |
| mbiomics | Munich | Series A | $12.0M | 2026-04-28 |
| Kupando | Schönefeld | Series A | $11.5M | 2026-03-18 |
| Mindpeak | Hamburg | Series A | $15.3M | 2024-09-30 |
| PL BioScience | Aachen | Series A | $8.5M | 2024-08-08 |
| SciRhom | Martinsried | Series A | $68.1M | 2024-07-09 |
| Insempra | Planegg | Series A | $20.0M | 2024-05-07 |
| traceless materials | Hamburg | Series A | $38.8M | 2023-09-25 |
8 rows of the CSV in 5 of its 18 columns.
- The 58 biotech startups in Germany whose last round is Series A have raised $489.2M in total.
- 6 of them closed their most recent round in the last 12 months, $70.2M combined.
- The largest of those rounds is T-CURX's $20.0M Series A, dated December 2025.
- The most recent is Cellbox Solutions' $1.7M Series A on 20 October 2026.
- HTGF (High-Tech Gruenderfonds) is an investor in 22 of them, more than any other fund.
- Health care is the most common other sector, with 43 companies (74%).
- 12% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (46% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 58| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
| mbiomics | mbiomics is a biotechnology company. | Biotech | Munich | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| Kupando | Kupando is a biopharmaceutical company developing agonists that stimulate innate immunity. | Biotech | Schönefeld | Series A | $11.5M | 2026-03-18 | $24.0M | HTGF (High-Tech Gruenderfonds), Brandenburg Kapital, Remiges Ventures +2 | 1 to 10 | 2018 |
| Mindpeak | Mindpeak develops AI-based diagnostic software that detects, quantifies, and classifies cancer. | Artificial intelligence | Hamburg | Series A | $15.3M | 2024-09-30 | European Innovation Council, EIC Accelerator, Nina Capital +2 | 11 to 50 | 2018 | |
| PL BioScience | PL BioScience delivers 2D and 3D cell culture solutions based on human Platelet Lysate. | Biotech | Aachen | Series A | $8.5M | 2024-08-08 | $13.0M | TechVision Fund, better ventures, Brightlands Venture Partners +1 | 11 to 50 | 2015 |
| traceless materials | traceless materials develops circular bioeconomy alternatives to conventional plastics and bioplastics. | Biotech | Hamburg | Series A | $38.8M | 2023-09-25 | HTGF (High-Tech Gruenderfonds), European Innovation Council, Planet A Ventures +2 | 51 to 100 | 2020 | |
| anvajo | anvajo is a Dresden-based company that develops, manufactures and sells liquid analysis solutions. | Biotech | Dresden | Series A | $17.3M | 2022-10-19 | Think.Health, Die Brückenköpfe, Johnsonville Ventures | 51 to 100 | 2016 | |
| GeneQuine Biotherapeutics | GeneQuine Biotherapeutics develops gene therapy for treating osteoarthritis. | Biotech | Hamburg | Series A | $6.6M | 2021-02-15 | HTGF (High-Tech Gruenderfonds), IFB Innovationsstarter, Meusinvest (Noshaq) | 1 to 10 | 2011 | |
| Cytena | Cytena develops single-cell printing technology for cell research and professional diagnostics. | Biotech | Freiburg | Series A | $3.4M | 2019-03-26 | $4.6M | HTGF (High-Tech Gruenderfonds), VentureOut | 101 to 250 | 2014 |
| Luxendo | Luxendo develops and manufactures proprietary light-sheet fluorescence microscopy instruments. | Biotech | Heidelberg | Series A | $8.5M | 2017-01-12 | EQT Life Sciences, EMBL Ventures, LSP BioVentures | 11 to 50 | 2015 | |
| ELARA Pharmaceuticals | ELARA Pharmaceuticals provides research and development services for new anti-cancer drugs. | Biotech | Heidelberg | Series A | $6.9M | 2009-11-26 | KfW, EMBL Ventures, WFT | 11 to 50 | 2006 | |
| BioPheresis | BioPheresis Technologies, based in Heidelberg, Germany, develops a blood treatment system aimed at curing cancer. | Biotech | Heidelberg | Series A | $8.0M | 2005-05-13 | firstVentury Equity, SLS Venture | 1 to 10 | 2003 |
Table 1. Biotech startups that raised Series A in Germany: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 58.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | mbiomics | mbiomics is a biotechnology company. | Biotech | Munich | Series A | $12.0M | 2026-04-28 | $26.1M | HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital | 11 to 50 | 2020 |
| 2 | Kupando | Kupando is a biopharmaceutical company developing agonists that stimulate innate immunity. | Biotech | Schönefeld | Series A | $11.5M | 2026-03-18 | $24.0M | HTGF (High-Tech Gruenderfonds), Brandenburg Kapital, Remiges Ventures +2 | 1 to 10 | 2018 |
| 3 | Cellbox Solutions | Cellbox Solutions provides logistics solutions for the global biomedical industry. | Biotech | Cologne | Series A | $1.7M | 2026-10-20 | $15.3M | European Innovation Council, Fraunhofer Venture, CK Venture Capital | 11 to 50 | 2017 |
Table 2. Biotech startups that raised Series A in Germany: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 22 | 38% | 2 | mbiomics, Kupando |
| 2 | KfW | Government investment office | Frankfurt, Germany | 6 | 10% | ||
| 3 | Bayern Kapital | Venture capital firm | Landshut, Germany | 5 | 9% | 1 | mbiomics |
| 4 | Fraunhofer Venture | Venture capital firm | Munich, Germany | 3 | 5% | 1 | Cellbox Solutions |
| 5 | European Innovation Council | Startup accelerator | Brussels, Belgium | 3 | 5% | 1 | Cellbox Solutions |
| 6 | EMBL Ventures | Venture capital firm | Heidelberg, Germany | 3 | 5% | ||
| 7 | MIG Capital | Venture capital firm | Munich, Germany | 2 | 3% | 1 | mbiomics |
| 8 | Andera Partners | Private equity firm | Paris, France | 2 | 3% | ||
| 9 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 2 | 3% | ||
| 10 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | 2 | 3% | ||
| 11 | Seventure Partners | Venture capital firm | Paris, France | 2 | 3% | ||
| 12 | LSP BioVentures | Venture capital firm | Cambridge, United States | 2 | 3% | ||
| 13 | LBBW VC | Corporate venture arm | Stuttgart, Germany | 2 | 3% | ||
| 14 | IFB Innovationsstarter | Venture capital firm | Hamburg, Germany | 2 | 3% | ||
| 15 | Cascara Ventures | Venture capital firm | Brussels, Belgium | 2 | 3% |
Table 3. Biotech startups that raised Series A in Germany: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 43 | 74% | $445.1M |
| Software | 4 | 7% | $19.0M |
| Artificial intelligence | 2 | 3% | $19.0M |
| Education | 1 | 2% | |
| Hardware | 1 | 2% |
Table 4. Biotech startups that raised Series A in Germany by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 58 | 100% | $9.6M |
Table 5. Biotech startups that raised Series A in Germany by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Munich | 5 | 9% |
| Hamburg | 5 | 9% |
| Berlin | 5 | 9% |
| Martinsried | 4 | 7% |
| Heidelberg | 3 | 5% |
| Tübingen | 2 | 3% |
| Freiburg | 2 | 3% |
| Planegg | 2 | 3% |
| Eßlingen | 2 | 3% |
| Cologne | 1 | 2% |
| Schönefeld | 1 | 2% |
| Würzburg | 1 | 2% |
Table 6. Biotech startups that raised Series A in Germany by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 17% | $1.7M |
| September 2026 | 1 | 17% | $13.7M |
| April 2026 | 1 | 17% | $12.0M |
| March 2026 | 2 | 33% | $22.8M |
| December 2025 | 1 | 17% | $20.0M |
Table 7. Biotech startups that raised Series A in Germany: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 9% | $50.2M |
| 2025 | 2 | 3% | $20.0M |
| 2024 | 6 | 10% | $115.7M |
| 2023 | 2 | 3% | $63.7M |
| 2022 | 2 | 3% | $17.3M |
| 2021 | 6 | 10% | $183.3M |
Table 8. Biotech startups that raised Series A in Germany by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 7 | 12% |
| 2015 to 2019 | 16 | 28% |
| 2010 to 2014 | 19 | 33% |
| Before 2010 | 15 | 26% |
Table 9. Biotech startups that raised Series A in Germany by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 25 | 44% |
| 11 to 50 | 26 | 46% |
| 51 to 100 | 3 | 5% |
| 101 to 250 | 1 | 2% |
| 501 to 1,000 | 2 | 4% |
Table 10. Biotech startups that raised Series A in Germany by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in Germany. On 16 November 2026 that is 58 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 58 rows: 18 have no round amount, 0 no city and 31 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Germany whose last round is Series A are on the list?
- 58, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 58 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.